Colorectal Cancer

Colorectal Cancer News & Features

Adherence to the 2018 WCRF/AICR recommendations as measured by a multicomponent “lifestyle score” was associated with a statistically significant decreased risk of CRC in men.

Lenvatinib Plus Pembrolizumab Safe, Effective in non-MSI-H/pMMR CRC

Colby Strong

January 15, 2021

LEAP-005 investigators tested the safety and efficacy of combination lenvatinib and pembrolizumab in 32 patients with previously treated advanced non–microsatellite instability-high (MSI-H)/mismatch repair proficient (pMMR) colorectal cancer (CRC).

Negative Prognosis Associated with KRAS Mutation Status in CRC May be Linked to Race/Ethnicity

Leah Lawrence

January 15, 2021

Investigators reviewed data from 202,237 patients from the Surveillance, Epidemiology, and End Results (SEER) registry who had been diagnosed CRC with 2010 and 2015.

Polypectomy Associated With Decreased Long-Term Risk for Colorectal Cancer

Colby Stong

January 1, 2021

Using data from the Minnesota Colon Cancer Control Study, a team of investigators assessed the impact of polypectomy on the incidence of colorectal cancer.

Quality Parameters Increase Clinically Relevant Colonoscopy Findings Including Colorectal Diseases and Cancer

Brandon May

December 31, 2020

Investigators found a high prevalence of clinically relevant colorectal diseases and cancer among patients undergoing colonoscopy when quality parameters were emphasized.

Some patients with rectal cancer who experience complete clinical response after neoadjuvant therapy

Disease Recurrence Risk for Patients With Rectal Cancer Followed With “Watch and Wait”

Susan Moench, PhD, PA-C

December 30, 2020

The “watch and wait” approach is characterized by close surveillance without surgery in patients with rectal cancer who achieve a clinical CR following neoadjuvant CRT.

Clinical Trials

Clinical Trial: Cytokine Changes After Colorectal Cancer Resection

Clinical Trial: Sentinel Concept in Early Stage Cervical Cancer

Clinical Trial: Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer or Polyposis Syndrome or Who Are at High Risk of Developing Hereditary Colorectal Cancer

Colorectal Cancer

Lenvatinib Plus Pembrolizumab Safe, Effective in non-MSI-H/pMMR CRC

Negative Prognosis Associated with KRAS Mutation Status in CRC May be Linked to Race/Ethnicity

Polypectomy Associated With Decreased Long-Term Risk for Colorectal Cancer

Quality Parameters Increase Clinically Relevant Colonoscopy Findings Including Colorectal Diseases and Cancer

Disease Recurrence Risk for Patients With Rectal Cancer Followed With “Watch and Wait”

Clinical Trials

Clinical Trial: Cytokine Changes After Colorectal Cancer Resection

Clinical Trial: Sentinel Concept in Early Stage Cervical Cancer

Clinical Trial: Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer or Polyposis Syndrome or Who Are at High Risk of Developing Hereditary Colorectal Cancer

Clinical Trial: Trial of Aspirin and Arginine Restriction in Colorectal Cancer

Clinical Trial: Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print

Fact Sheets

Metastatic Cancer (Fact Sheet)

Metastatic Colorectal Cancer and KRAS Gene Testing

Colorectal Cancer: The Importance of Screening and Early Detection

Coping with Colorectal Cancer

Colorectal Cancer: New Tools for Making Decisions About Treatment

Want to read more?

Quality Parameters Increase Clinically Relevant Colonoscopy Findings Including Colorectal Diseases and Cancer